← FDA DRUG APPROVALS

FDA ANDA · ANDA090164

TRIAMCINOLONE ACETONIDE

Sponsor: SANDOZ

APPLICATION
ANDA090164
TYPE
ANDA
ORIGINAL APPROVAL
2009-06-01
LATEST ACTION
2025-10-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 40MG/ML · INJECTABLE · INJECTION

Approval history

2025-10-08Labeling · Supplement 10 · standardAP
2019-10-03Labeling · Supplement 9 · standardAP
2012-11-13Labeling · Supplement 6 · standardAP
2011-03-18Labeling · Supplement 3AP
2009-06-01OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →